Quantum-Si (NASDAQ:QSI) Price Target Raised to $5.50

Quantum-Si (NASDAQ:QSI) had its price target boosted by analysts at HC Wainwright from $4.00 to $5.50 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 295.68% from the company’s current price. HC Wainwright also issued estimates for Quantum-Si’s Q4 2024 earnings at ($0.18) EPS, FY2024 earnings at ($0.65) EPS, Q1 2025 earnings at ($0.18) EPS, Q2 2025 earnings at ($0.17) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.17) EPS, FY2025 earnings at ($0.69) EPS, FY2026 earnings at ($0.56) EPS, FY2027 earnings at ($0.42) EPS and FY2028 earnings at ($0.22) EPS.

Separately, Canaccord Genuity Group cut their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, November 13th.

Quantum-Si Trading Up 119.6 %

Shares of QSI stock opened at $1.39 on Thursday. The company has a market capitalization of $197.88 million, a price-to-earnings ratio of -2.17 and a beta of 2.89. The firm has a 50-day moving average price of $0.85 and a 200 day moving average price of $1.09. Quantum-Si has a twelve month low of $0.61 and a twelve month high of $2.43.

Hedge Funds Weigh In On Quantum-Si

A number of large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of Quantum-Si by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after buying an additional 82,463 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Quantum-Si by 11.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Quantum-Si in the first quarter valued at $27,000. Jacobs Levy Equity Management Inc. acquired a new stake in Quantum-Si during the 1st quarter valued at $998,000. Finally, Virtu Financial LLC purchased a new stake in Quantum-Si during the 1st quarter worth $98,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.